We are live on ! Find out more
SQZ

SQZ Biotechnologies Company

Delisted

SQZ was delisted on the 3rd of July, 2023.

44 hedge funds and large institutions have $199M invested in SQZ Biotechnologies Company in 2021 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 20 increasing their positions, 14 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

43% more repeat investments, than reductions

Existing positions increased: 20 | Existing positions reduced: 14

25% more capital invested

Capital invested by funds: $159M → $199M (+$39.7M)

10% less funds holding

Funds holding: 4944 (-5)

71% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 7

Holders
44
Holders Change
-5
Holders Change %
-10.2%
% of All Funds
0.77%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
20
Reduced
14
Closed
7
Calls
$164K
Puts
Net Calls
+$164K
Net Calls Change
+$164K
Name Holding Trade Value Shares
Change
Change in
Stake
RAM
26
Redmond Asset Management
Virginia
$237K
New York State Common Retirement Fund
27
New York State Common Retirement Fund
New York
$208K -$69.2K -5,109 -26%
Manulife (Manufacturers Life Insurance)
28
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$191K -$9.04K -667 -5%
California State Teachers Retirement System (CalSTRS)
29
California State Teachers Retirement System (CalSTRS)
California
$176K -$260K -19,183 -61%
EMG
30
ETF Managers Group
New Jersey
$146K +$25.8K +1,907 +23%
MIM
31
MetLife Investment Management
New Jersey
$137K +$129K +9,534 New
MLICM
32
Metropolitan Life Insurance Company (MetLife)
New York
$104K +$97.8K +7,213 New
UBS Group
33
UBS Group
Switzerland
$101K +$43.8K +3,233 +86%
Morgan Stanley
34
Morgan Stanley
New York
$94K -$2.14M -157,673 -96%
BAM
35
Baldrige Asset Management
Pennsylvania
$72K -$6.06K -447 -8%
Royal Bank of Canada
36
Royal Bank of Canada
Ontario, Canada
$44K +$20.3K +1,500 +96%
Citigroup
37
Citigroup
New York
$37K +$20.5K +1,512 +140%
AIP
38
Ameritas Investment Partners
Nebraska
$26K
Legal & General Group
39
Legal & General Group
United Kingdom
$26K
Rockefeller Capital Management
40
Rockefeller Capital Management
New York
$12K +$6.78K +500 +128%
TRCT
41
Tower Research Capital (TRC)
New York
$8K -$207K -15,276 -97%
HI
42
Hudock Inc
Pennsylvania
$7K -$515 -38 -7%
FDCDDQ
43
Federation des caisses Desjardins du Quebec
Quebec, Canada
$1.51K
LM
44
Luminus Management
Texas
-$5.11M -353,895 Closed
Jacobs Levy Equity Management
45
Jacobs Levy Equity Management
New Jersey
-$1M -69,189 Closed
Acadian Asset Management
46
Acadian Asset Management
Massachusetts
-$668K -46,249 Closed
JF
47
Jump Financial
Illinois
-$389K -26,955 Closed
CSS
48
Cubist Systematic Strategies
Connecticut
-$325K -22,524 Closed
SO
49
STRS Ohio
Ohio
-$15K -1,100 Closed
PA
50
Parallel Advisors
California
-$1K -74 Closed

SQZ Hedge Fund Activity: Q3 2021 in Review

44 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in SQZ Biotechnologies Company (SQZ) for Q3 2021, worth a combined $199M — up 25% from $159M a quarter earlier.

Sellers outnumbered buyers: 7 funds closed out of SQZ and 2 opened new positions — a net loss of 5 holders — while 14 trimmed existing stakes and 20 added.

The largest buyer was 683 Capital Management, adding an estimated $4.3M. The largest seller was Luminus Management, exiting entirely with an estimated $5.11M sold.

  • 44 institutional investors held SQZ Biotechnologies Company (SQZ) as of Q3 2021, down from 49 in Q2 2021.
  • Funds reported $199M of SQZ Biotechnologies Company stock for Q3 2021, up 25% quarter-over-quarter.
  • 2 funds opened new SQZ Biotechnologies Company positions in Q3 2021 and 7 closed out, a net change of -5 holders.
  • The largest SQZ Biotechnologies Company buyer in Q3 2021 was 683 Capital Management, an estimated $4.3M added.
  • The largest SQZ Biotechnologies Company seller in Q3 2021 was Luminus Management, an estimated $5.11M sold.

Based on aggregated 13F filings for Q3 2021.